The Green Brief



    Lead Story
    Cannabis Sector Slumps as Rescheduling Debate Intensifies
    Cannabis equities retreated broadly on Thursday, with CURLF falling 4.06% and TLRY dropping 2.90%, as investor sentiment remained cautious amid ongoing uncertainty over federal rescheduling timelines. NORML has publicly stated that moving cannabis to Schedule III falls short of what the industry needs, arguing that only full descheduling would resolve core obstacles including 280E tax burdens and interstate commerce restrictions. Meanwhile, the Rockefeller Institute of Government released an analysis underscoring that rescheduling alone would leave most state-licensed operators without meaningful federal relief, keeping banking access and tax parity out of reach for the foreseeable future.
    Full analysis →

    

    Policy & Regulatory Watch
    
      State
      Virginia lawmakers are eyeing cannabis legislation as a potential mechanism to break a prolonged state budget impasse, according to MJBizDaily.
    
    
      State
      Illinois passed a broad cannabis industry overhaul bill headed to Governor Pritzker's desk, while a separate cannabis and hemp regulation measure also advanced through the legislature.
    
    
      Federal
      An Indiana Capital Chronicle op-ed argues that federal reclassification of medical marijuana, while long overdue, is insufficient without accompanying banking and tax reform.
    

    

    Market Pulse
    
      
        MSOS
        $5.36
        -2.37%
      
      
        CURLF
        $10.39
        -4.06%
      
      
        TLRY
        $5.02
        -2.90%
      
      
        GTBIF
        $8.47
        -2.17%
      
      
        CRLBF
        $0.89
        -1.13%
      
      
        AYRWF
        $0.02
        +3.23%
      
    

    

    Quick Hits
    
      
      
        Tilray Medical Germany launched ARX™, a new premium medical cannabis brand cultivated domestically under rigorous German quality standards, targeting patients and healthcare professionals across the country.
        Financial Post · 18h ago
      
    
    
      
      
        Texas's rule targeting smokable hemp products has returned to effect following a legal battle, though enforcement mechanisms remain ambiguous for retailers and producers statewide.
        Houston Public Media · 12h ago
      
    
    
      
      
        High-potency cannabis is driving fresh legislative debates across multiple states, with lawmakers weighing restrictions amid mounting clinical concern over psychosis and addiction risk.
        News From The States · 14h ago
      
    
    
      
      
        CannBro showcased cannabis compliance technology, medical applications, and supply chain innovation at Cannabis Expo Johannesburg 2026, reflecting growing institutional interest in Africa's emerging regulated market.
        GlobeNewswire · 20h ago
      
    

    

    From the Culture Desk
    
      
      
        After RFK: The Cannabis Festival Trail Still Has Three Big Stops Left
        The National Cannabis Festival pulled 25,000+ to RFK Stadium in April and may be the last one ever held there. The summer 2026 calendar has three stops that matter — a Midwest weekender in southern Ohio, a redwood-canopy gathering in Northern California that just became the first US festival with legal on-site sales, and a one-day civic anchor in Pittsburgh. A field guide.
        Read on cannanews.io →
        8 min read
      
    

    

    
      Seed & Stem — Today’s Context
      Several states require cannabis license applicants to demonstrate in-state residency for a defined period, a rule that has faced repeated dormant Commerce Clause challenges in federal court. Maine, Missouri, and others have lost residency-rule cases, gradually opening their markets to multistate capital.
The Green Brief — Jun 11, 2026
